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PrefaceBacteria are responsible for more than 25% of deaths
worldwide. The emergence of bacterial strains resistant to even
the most powerful antibiotics is a growing problem that
threatens our ability to treat infection. Therefore, there is an
urgent need to develop new antibiotics. Natural antimicrobial
peptides probably represent one of the very first evolved forms
of chemical defense of living eukaryotic cells against invasion
by other living organisms. Most antimicrobial peptides kill
bacteria by disrupting their membranes, and these peptides may
be developed into a new line of defense against infectious
diseases. Antimicrobial peptides have survived in this role over
evolutionary time scales, likely because they are less susceptible
to the development of bacterial resistance. Therefore, attempts
are increasingly being made to develop similar peptides as a
new class of antibiotics, antiviral and anticancer compounds.
The dramatically increasing numbers of newly discovered
antimicrobial peptides, publications, meetings and funding
support indicate the current importance of this field.
This special issue of the journal presents a broad spectrum of
exciting studies on antimicrobial peptides from various research
laboratories in the form of reviews and original research articles.
The articles cover recent advances and the most important
challenges in this area of research. Some of the exciting
questions addressed in this issue are: (1) Is it possible to
measure atomistic-level structure, dynamics, geometry, and
membrane interaction of antimicrobial peptides obtained from a0005-2736/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2006.08.003biologically relevant environment? (2) Can existing biophysical
and biochemical approaches provide physiologically relevant
information on antimicrobial peptides? (3) How do antimicro-
bial peptides carry out their broad spectrum of activity and how
can these functions be altered for biomedical or biotechnolo-
gical purposes? (4) Is it possible to design potent peptide
antibiotics for pharmaceutical applications?
The topic and contents of this special issue were conceived as
a result of the high-quality presentations and exciting discus-
sions at theMembrane Biophysics Symposium onAntimicrobial
Peptides at the University of Michigan (September 2005).
Therefore, I thank all the participants and sponsors of this
symposium. I also thank all the authors and reviewers who made
contributions to this special issue, as well as the editors of the
journal and my family for their help in bringing out this issue. I
am sure that the researchers in this field will find the articles to be
valuable in furthering the development and characterization of
new classes of pharmaceutical compounds.Ayyalusamy Ramamoorthy
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